Exposure to PFAS in drinking water linked to higher blood levels of these 'forever' chemicals
First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat
First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat
From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing
The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept
New findings at ADLM 2025 could remedy this failure
Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025
Discover how Waters' HRMS innovations are enhancing the accuracy and scope of PFAS detection and analysis
The award recognises Gradientech’s impactful and innovative campaign to raise awareness about its QuickMIC ultra-rapid antibiotic susceptibility testing (AST) system
With a bold new identity and expanded capabilities, HiArc emerges as a next-generation engineering and manufacturing partner for the life science and diagnostics industry
New solution delivers high-integrity DNA exceeding 100 kb in under two hours, supporting automation across KingFisher platforms to accelerate long-read sequencing research
ADLM 2025 studies highlight promising options for cervical and endometrial cancer
Forging a powerful partnership to accelerate global healthcare innovation and dominate the emerging AI-driven clinical decision support market
Innovations in diagnostics and lab advocacy
Discover how advances in dried blood spot testing are advancing biomarker analysis and sample collection
To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
Multicenter study shows IntelliSep enables an increase in safe ED discharges, easing inpatient bed shortages without increasing 30-day return visits